BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23969241)

  • 1. [IMRT and head and neck tumors: does differential fractionation have a role?].
    Giraud P; Servagi-Vernat S
    Cancer Radiother; 2013 Oct; 17(5-6):502-7. PubMed ID: 23969241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
    Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
    J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
    Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
    Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review.
    Orlandi E; Palazzi M; Pignoli E; Fallai C; Giostra A; Olmi P
    Crit Rev Oncol Hematol; 2010 Feb; 73(2):111-25. PubMed ID: 19409808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult.
    Ho KF; Fowler JF; Sykes AJ; Yap BK; Lee LW; Slevin NJ
    Acta Oncol; 2009; 48(3):431-9. PubMed ID: 18781445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated radiotherapy with simultaneous integrated boost fractionation and intensity-modulated radiotherapy for advanced head and neck cancer.
    Schwartz M; Vuong T; Ballivy O; Parker W; Patrocinio H
    Otolaryngol Head Neck Surg; 2007 Apr; 136(4):549-55. PubMed ID: 17418249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G; Huguenin PU; Davis JB; Kunz G; Lütolf UM; Glanzmann C
    Radiat Oncol; 2006 Mar; 1():7. PubMed ID: 16722599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Image-guided radiotherapy for head and neck carcinoma].
    Beddok A; Blanchard P
    Cancer Radiother; 2018 Oct; 22(6-7):617-621. PubMed ID: 30143464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Options for combining altered fractionation with IMRT.
    Allen AM; Wolfsberger L; Tishler RB; Court LE
    Technol Cancer Res Treat; 2008 Dec; 7(6):457-61. PubMed ID: 19044325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intensity-modulated radiation therapy and stereotactic body radiation therapy for head and neck tumors: evidence-based medicine].
    Lapierre A; Martin F; Lapeyre M
    Cancer Radiother; 2014 Oct; 18(5-6):468-72. PubMed ID: 25155467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
    Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
    Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary analysis of the sequential simultaneous integrated boost technique for intensity-modulated radiotherapy for head and neck cancers.
    Miyazaki M; Nishiyama K; Ueda Y; Ohira S; Tsujii K; Isono M; Masaoka A; Teshima T
    J Radiat Res; 2016 Jul; 57(4):406-11. PubMed ID: 26983983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of clinical outcomes between simultaneous integrated boost (SIB) versus sequential boost (SEQ) intensity modulated radiation therapy (IMRT) for head and neck cancer: A meta-analysis.
    Jiang L; Zhang Y; Yang Z; Liang F; Wu J; Wang R
    Medicine (Baltimore); 2019 Aug; 98(34):e16942. PubMed ID: 31441887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
    Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
    Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Lertbutsayanukul C; Prayongrat A; Kannarunimit D; Chakkabat C; Netsawang B; Kitpanit S
    Strahlenther Onkol; 2018 May; 194(5):375-385. PubMed ID: 29302704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity.
    Peñagarícano JA; Moros EG; Ratanatharathorn V; Yan Y; Corry P
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1369-75. PubMed ID: 19625138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin dose differences between intensity-modulated radiation therapy and volumetric-modulated arc therapy and between boost and integrated treatment regimens for treating head and neck and other cancer sites in patients.
    Penoncello GP; Ding GX
    Med Dosim; 2016; 41(1):80-6. PubMed ID: 26764180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vestibular disorders and nausea during head and neck intensity-modulated radiation therapy].
    Berta É; Righini CA; Chamorey E; Villa J; Atallah I; Reyt É; Coffre A; Schmerber S
    Cancer Radiother; 2016 Jun; 20(4):255-60. PubMed ID: 27318553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and efficacy of cetuximab associated with several modalities of IMRT for locally advanced head and neck cancer.
    Bibault JE; Morelle M; Perrier L; Pommier P; Boisselier P; Coche-Dequéant B; Gallocher O; Alfonsi M; Bardet É; Rives M; Calugaru V; Chajon E; Noël G; Mecellem H; Pérol D; Dussart S; Giraud P
    Cancer Radiother; 2016 Jul; 20(5):357-61. PubMed ID: 27345843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderately accelerated intensity-modulated radiation therapy using simultaneous integrated boost: Practical reasons or evidence-based choice? A critical appraisal of literature.
    De Felice F; Bonomo P; Sanguineti G; Orlandi E
    Head Neck; 2020 Nov; 42(11):3405-3414. PubMed ID: 32767530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.